Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interaction management.

Philip D Hansten1

  • 1University of Washington, 1959 NE Pacific Street, Seattle, WA 98196-7630, USA. hansten@uwashington.edu

Pharmacy World & Science : PWS
|July 5, 2003
PubMed
Summary

Patients still experience adverse drug interactions despite extensive research and screening systems. Strategies to mitigate risks include enhancing provider knowledge, improving screening tools, and educating patients on drug interactions and risk factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics.

Pharmacotherapy·2025
Same author

Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration.

Cancer treatment reviews·2024
Same author

Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).

The Annals of pharmacotherapy·2023
Same author

Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).

The Annals of pharmacotherapy·2023
Same author

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management.

Drug safety·2022
Same author

Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review.

Studies in health technology and informatics·2022

Area of Science:

  • Pharmacology
  • Patient Safety
  • Drug Interactions

Background:

  • Despite extensive research and numerous computerized screening systems for drug interactions, adverse events persist.
  • Patient harm from drug interactions remains a significant public health concern.

Purpose of the Study:

  • To identify key strategies for reducing the incidence and impact of adverse drug interactions.
  • To highlight areas for improvement in healthcare systems and patient engagement.

Main Methods:

  • Review of existing literature and clinical practice guidelines on drug interactions.
  • Analysis of factors contributing to the failure of current drug interaction prevention methods.

Main Results:

  • Identified several critical areas for intervention, including healthcare provider education and enhanced screening systems.
  • Highlighted the importance of patient-specific factors, pharmacogenetics, and drug administration details.
  • Emphasized the need for improved patient education on managing drug interactions.

Conclusions:

  • A multi-faceted approach is necessary to reduce adverse drug interactions.
  • Improving healthcare provider knowledge, utilizing advanced screening technologies, and empowering patients with information are crucial for enhancing medication safety.

Related Experiment Videos